Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New approach aims to reduce uterine scarring after pregnancy complications

NCT ID NCT07421895

Summary

This study aims to find the best treatment for retained pregnancy tissue (RPOC) to protect women's future fertility. Researchers will compare whether using medication and carefully timed surgery causes less uterine scarring than immediate surgery. The study will follow 600 women to see which approach better prevents scarring and helps achieve pregnancy within a year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETAINED PRODUCTS OF CONCEPTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 410013, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.